A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/44 (2006.01) A61K 31/4406 (2006.01)
Patent
CA 2215160
The present invention relates to the use of ridogrel for the manufacture of a medicament for treating inflammatory bowel diseases, wherein ridogrel is administered in a daily dose from 0.01 mg/kg body weight to 0.5 mg/kg body weight; pharmaceutical compositions comprising ridogrel.
La présente invention se rapporte à l'utilisation du ridogrel dans la fabrication d'un médicament traitant des maladies intestinales inflammatoires, auquel cas le ridogrel est administré sous dose journalière de 0,01 mg/kg à 0,5 mg/kg de poids corporel; ainsi qu'aux compositions pharmaceutiques incluant le ridogrel.
Gowling Lafleur Henderson Llp
Janssen Pharmaceutica N.v.
Janssen Pharmaceutica N.v.
LandOfFree
Low dose ridogrel formulations and their use for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Low dose ridogrel formulations and their use for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low dose ridogrel formulations and their use for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1466056